Engineers Gate Manager LP Global Blood Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $623,173 - $1.04 Million	-27,945 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $94,194 - $130,544	3,668 Added 15.11%	27,945 $968,000
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $76,965 - $124,443	-3,091 Reduced 11.29%	24,277 $711,000
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $697,336 - $1.02 Million	27,368 New	27,368 $697,000
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $586,172 - $992,835	-15,569 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $821,420 - $1.16 Million	15,569 New	15,569 $858,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $209,851 - $438,616	-5,030 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $229,871 - $411,755	5,030 New	5,030 $400,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.